The weed wire 1933 Industries posts declining revenues in Q2 report 1933 attributed most of the losses to the completion of two cost-heavy projects Nick LabaApril 1, 2020
The weed wire Delta 9 pranks Twitter with April Fools’ Day outdoor winter weed Hearty cultivar brings a new meaning to frosty trichomes, company says Michelle GamageApril 1, 2020
Analysis ‘Guys, we have one job: survive’ Analysis: Business professor says weed companies have to make tough decisions to survive the oncoming recession, as his did in the dot-com era Nick LabaApril 1, 2020
Culture SPLIFF Film Festival now streaming straight to stoners’ couches Dan Savage's 420 festival moves online amidst COVID-19 fears Michelle GamageMarch 31, 2020
Industry update Valens, Columbia Care both make stock listing moves Columbia Care is the first U.S. operator to get a dual listing in Canada, while BC-based Valens is set to graduate to the TSX Jared GnamMarch 31, 2020
Cannabis Health Canada OKs health product production, considers licence extensions in new guidance to LPs Product testing still has to be conducted by licensed laboratories Nick LabaMarch 31, 2020
Canada NORML Canada’s new executive director Caryma Sa’d explains how legalization went wrong: Q&A After 42 years of lobbying for cannabis policy reform, the advocacy group is refocusing its mandate to promote equitable, functional weed laws Michelle GamageMarch 31, 2020
Canada MediPharm blames slow cannabis 2.0 rollout for Q4 revenue drop The cannabis extractor saw its share price slide 18 per cent after posting a sizeable decline in Q4 revenue Jared GnamMarch 30, 2020
Canada Hexo reports $300M in losses, claims value product is beating black market The producer's cash position looks grim going into the coming months Nick LabaMarch 30, 2020
Canada Can cannabis treat COVID-19? Toronto firm hopes clinical trial will provide answers As misinformation spreads like a virus, Cannalogue wants to conduct research to see if CBD can be used to fight the pandemic Jared GnamMarch 28, 2020